Immucell (ICCC) Current Assets (2016 - 2025)
Historic Current Assets for Immucell (ICCC) over the last 16 years, with Q3 2025 value amounting to $16.8 million.
- Immucell's Current Assets rose 2115.35% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year increase of 2115.35%. This contributed to the annual value of $15.0 million for FY2024, which is 3115.04% up from last year.
- As of Q3 2025, Immucell's Current Assets stood at $16.8 million, which was up 2115.35% from $17.1 million recorded in Q2 2025.
- Immucell's 5-year Current Assets high stood at $18.3 million for Q1 2022, and its period low was $10.8 million during Q2 2024.
- Its 5-year average for Current Assets is $14.4 million, with a median of $15.0 million in 2024.
- Per our database at Business Quant, Immucell's Current Assets soared by 6177.04% in 2021 and then plummeted by 3683.47% in 2023.
- Quarter analysis of 5 years shows Immucell's Current Assets stood at $16.3 million in 2021, then fell by 13.96% to $14.0 million in 2022, then fell by 18.04% to $11.5 million in 2023, then soared by 31.15% to $15.0 million in 2024, then grew by 11.85% to $16.8 million in 2025.
- Its last three reported values are $16.8 million in Q3 2025, $17.1 million for Q2 2025, and $15.9 million during Q1 2025.